[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS)

NewAmsterdam Pharma's Obicetrapib shows promising results in Alzheimer's and cardiovascular trials, sparking significant investor interest and potential acquisition rumors. Analysts highlight its potential as a foundational therapy with strong efficacy and safety data.

### About NewAmsterdam Pharma Company N.V. Ordinary Shares
NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) is a stock in the healthcare sector.  
NewAmsterdam Pharma Company N.V. Ordinary Shares uses the ticker $NAMS for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) social dominance hit XXXXXX which is XXX% higher than it's daily average.
- NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) market dominance near a 52-week low at XXXXXXX.
- NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) trading volume is up XXXXXX% from the previous week.
- NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) social dominance is up XXXXXX% from the previous X months.
- NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) Galaxy Score™ is up XXXXX% from the previous week.

### Price: $XXXXX
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$nams/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$nams/time-series/close.tsv)  
NAMS is trading near its 52-week high, supported by positive market sentiment, strong gains, high trading volume, and anticipation of potential acquisition news, as indicated by recent social posts highlighting significant gains and positive market sentiment.  

24-Hour: XXXX%
7-Day: -XXX%
30-Day: -XXXX%

1-Year High: $XXXXX on 2025-11-26  
1-Year Low: $XXXXX on 2025-04-10  
  
  
### AltRank: XXXXX
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$nams/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$nams/time-series/alt_rank.tsv)  
NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) is currently AltRank #1,123 based on combined combined social and market metrics
Daily Average: XXXXX  
X Week: XXXXX +4  
X Month: XXXXX -XX  
1-Year High: XXXXX on 2025-09-08  
1-Year Low: X on 2025-10-12  
  
  
### Galaxy Score: XXXXX
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$nams/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$nams/time-series/galaxy_score.tsv)  
Current Value: XXXXX  
Daily Average: XX  
X Week: XX +10  
X Month: XX +4  
1-Year High: XX on 2025-11-22  
1-Year Low: XX on 2025-09-23  
  
  
### Engagements: XXXXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$nams/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$nams/time-series/interactions.tsv)  
Current Value: XXXXX  
Daily Average: XXXXX  
X Week: XXXXXX -XX%  
X Month: XXXXXXX +88%  
X Months: XXXXXXX +44%  
X Year: XXXXXXXXX +102%  
1-Year High: XXXXXX on 2025-11-15  
1-Year Low: XXX on 2025-10-29  

Engagements by network (24h):
X: XXXXX

  
  
### Mentions: XX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$nams/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$nams/time-series/posts_active.tsv)  
Current Value: XX  
Daily Average: XX  
X Week: XXX -XXXX%  
X Month: XXX +4.10%  
X Months: XXXXX +212%  
X Year: XXXXX +142%  
1-Year High: XXX on 2025-06-28  
1-Year Low: X on 2025-04-28  

Mentions by network (24h):
X: XXX

  
  
### Creators: XX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$nams/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$nams/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX  
X Week: XX -XX%  
X Month: XXX -XX%  
X Months: XXXXX +280%  
X Year: XXXXX +250%  
1-Year High: XXX on 2025-06-28  
1-Year Low: X on 2025-04-28  

The most influential creators that mention NewAmsterdam Pharma Company N.V. Ordinary Shares in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@Biotech2k1](/creator/twitter/Biotech2k1)           | X    | XXXXXX    | X     | XXX         |
| [@JoseRestonVA](/creator/twitter/JoseRestonVA)       | X    | XXXXX     | X     | XXX         |
| [@doctorvasan](/creator/twitter/doctorvasan)         | X    | XXXXX     | X     | XXX         |
| [@StockTickerZone](/creator/twitter/StockTickerZone) | X    | XXXXX     | X     | XXX         |
| [@BuyTheUgly](/creator/twitter/BuyTheUgly)           | X    | XX        | X     | XX          |
| [@BiopharmIQ](/creator/twitter/BiopharmIQ)           | X    | XXXXXX    | X     | XX          |
| [@RosaJim94865433](/creator/twitter/RosaJim94865433) | X    | XXX       | X     | XX          |
| [@seedytx19](/creator/twitter/seedytx19)             | X    | XXXXX     | X     | XX          |
| [@Beverly97739735](/creator/twitter/Beverly97739735) | X    | XXX       | X     | XX          |
| [@SteveDJacobs](/creator/twitter/SteveDJacobs)       | XX   | XXXXX     | X     | XX          |

[View More](/list/creators/$nams/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$nams/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$nams/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XXX% no change  
X Month: XXX% +20%  
X Months: XXX% +9%  
X Year: XXX% +2%  
1-Year High: XXX% on 2024-12-25  
1-Year Low: XX% on 2025-09-14  

Most Supportive Themes:
- Bullish Momentum and High-Probability Setups: (40%) Traders are actively seeking and sharing high-probability setups, capitalizing on recent gains and anticipating further upward movement.
- Strong Performance and Positive Market Sentiment: (35%) Posts highlight strong gains, with mentions of significant percentage increases, and overall positive sentiment towards the stock.
- Community Engagement and Watchlist Mentions: (25%) Active engagement within the community, with users sharing watchlists and encouraging others to join groups for insights and opportunities.
  
Most Critical Themes:
- Network Engagement Breakdown: (5%) The majority of the network engagement is neutral, with a small percentage of negative engagement.
  
  
  
### Social Dominance: XXXXXXX%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$nams/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$nams/time-series/social_dominance.tsv)  
Current Value: XXXXXXX%  
Daily Average: XXXXXXX%  
X Week: XXXXX% +0.0095%  
X Month: XXXXX% +0.013%  
X Months: XXXXX% +0.018%  
X Year: XXXXX% -XXXXXX%  
1-Year High: XXXX% on 2024-12-12  
1-Year Low: XXXXX% on 2025-09-05  
  
  
### Market Dominance: XXXXXXX%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$nams/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$nams/time-series/market_dominance.tsv)  
Current Value: XXXXXXX%  
Daily Average: X%  
1-Year High: XXXXX% on 2025-11-26  
1-Year Low: XXXXXXX% on 2025-12-10  
  
  
### Market Cap: $XXXXXXXXXXXXX
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$nams/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$nams/time-series/market_cap.tsv)  
Current Value: $XXXXXXXXXXXXX  
Daily Average: $XXXXXXXXXXXXX  
X Week: $XXXXXXXXXXXXX +$0.25%  
X Month: $XXXXXXXXXXXXX -$8.60%  
1-Year High: $XXXXXXXXXXXXX on 2025-11-26  
1-Year Low: $XXXXXXXXXXXXX on 2025-08-28  

### Top NewAmsterdam Pharma Company N.V. Ordinary Shares Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"$NAMS NewAmsterdam: Obicetrapib MAA Filings Merit Continued 'Buy' Rating (NASDAQ:NAMS) - Seeking Alpha #stocks #news"  
[X Link](https://x.com/StockTickerZone/status/1998712167303098382) [@StockTickerZone](/creator/x/StockTickerZone) 2025-12-10T11:11Z 3948 followers, XXX engagements


"This is HUGE $BMRN $ALEC $ALLO $SUPN $TRVI $BIIB $ARVN $ZURA $NVAX $JAZZ $SBTX $IDYA $INCY $EXEL $CMRX $ALKS $NAMS $ABCL $DAWN $ICPT $IRTC $ACHL $PTGX $KRYS $TGTX $PRVB $ENta $RXRX $AMRN $IRWD $URGN $RPTX $SAGE $ARWR $VACC $TWST $FOLD $MRTX"  
[X Link](https://x.com/BuyTheUgly/status/1998485178570977473) [@BuyTheUgly](/creator/x/BuyTheUgly) 2025-12-09T20:09Z XX followers, XXX engagements


"@simonmaechling There is still hope left for AD patients in CETPI Obicetrapib by $NAMS. One factor that distinguishes it from rest of the failed pursuits is support from Mendelian Randomization studies not to mention a robust XX% decline in p-tau217. Watch out for Ph2B trial to start soon"  
[X Link](https://x.com/doctorvasan/status/1998475209087566255) [@doctorvasan](/creator/x/doctorvasan) 2025-12-09T19:29Z 1503 followers, XXX engagements


"I nibbled some of $MIRM $ARQT $TVTX $LQDA $IMNM and $NAMS. That should get me back to my 50/50 weight of stocks and cash for $XBI $XXX. Now I can sell more stocks at higher price later as the FOMO goes to $130"  
[X Link](https://x.com/Biotech2k1/status/1998414312717836651) [@Biotech2k1](/creator/x/Biotech2k1) 2025-12-09T15:27Z 33.1K followers, 2169 engagements